Erlotinib for Treatment of Psoriasis
NCT01006096 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL
Last updated 2014-11-10
Summary
The purpose of this study is to determine whether erlotinib is effective in the treatment of psoriasis.
Conditions
Interventions
- DRUG
-
erlotinib
100mg tablet, once daily for 16 weeks
- OTHER
-
placebo tablet
placebo tablet (lactose), once daily for 16 weeks
Sponsors & Collaborators
-
OSI Pharmaceuticals
collaborator INDUSTRY - lead OTHER
Principal Investigators
-
Anne E Laumann, MBChB, MRCP (UK) · Northwestern University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- United States
Study Locations
More Related Trials
-
A Study of HS-20137 in Participants with Moderate-to-severe Plaque Psoriasis
NCT06844799 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
A Study to Evaluate Efficacy and Safety of HS-10374 for Mild-to-moderate Plaque Psoriasis
NCT06926582 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Efficacy of AIN457 in Adults (18-65 Years) With Psoriatic Arthritis
NCT00809614 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of HS-10374 Compared to Placebo in Adults With Active Psoriatic Arthritis
NCT06176508 ·Status: RECRUITING ·Phase: PHASE2
-
A Study of JNJ-77242113 in Participants With Moderate-to-severe Plaque Psoriasis
NCT05223868 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate Efficacy and Safety of HS-10374 for Moderate to Severe Plaque Psoriasis
NCT06077331 ·Status: RECRUITING ·Phase: PHASE2
-
Study to Investigate the Safety, Tolerability, Absorption, Distribution, Metabolism, and Elimination of RWJ-445380 Administered to Patients With Plaque Psoriasis
NCT00396422 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of LY3972406 in Adult Participants With Moderate-to-Severe Plaque Psoriasis
NCT06176768 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of BMS-582949 in Patients With Moderate to Severe Plaque Psoriasis
NCT00399906 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of JNJ-77242113 for the Treatment of Moderate-to-Severe Plaque Psoriasis
NCT05357755 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Confirm Efficacy and Safety of HS-10374 for Moderate to Severe Plaque Psoriasis
NCT06672393 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2)
NCT03535194 ·Status: COMPLETED ·Phase: PHASE3
-
A Trial Comparing SHR-1139 Injection With Placebo in Patients With Moderate-to-severe Plaque Psoriasis
NCT06875934 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Multi-Dose Study of SHR-1314 in Subjects With Moderate-to-severe Plaque Psoriasis
NCT03463187 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Apremilast in Palmo-Plantar Psoriasis
NCT02400749 ·Status: COMPLETED ·Phase: PHASE4
-
A Clinical Study of SHR-1314 Injection in the Treatment of Moderate to Severe Plaque Psoriasis in Adults
NCT04121143 ·Status: SUSPENDED ·Phase: PHASE2
-
Paired Psoriasis Lesion, Comparative, Study to Evaluate MOL4239 in Psoriasis
NCT01826201 ·Status: COMPLETED ·Phase: PHASE2
-
Psoriatic Arthritis Study of Izokibep
NCT05623345 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
A Phase 3 Study in Participants With Moderate to Severe Psoriasis
NCT01474512 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Safety and Efficacy of Efalizumab in Adult Patients With Moderate to Severe Plaque Psoriasis With Involvement of the Scalp
NCT00669214 ·Status: COMPLETED ·Phase: PHASE4
-
Dose Ranging Study of the Safety and Efficacy of R115966 in Plaque Psoriasis
NCT00716144 ·Status: COMPLETED ·Phase: PHASE2
-
Multiple-loading Dose Regimen Study in Patients With Chronic Plaque-type Psoriasis
NCT00805480 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Plaque Psoriasis
NCT05600036 ·Status: COMPLETED ·Phase: PHASE2
-
A Long-term Study to Evaluate Safety and Maintenance of Treatment Effect of LY3074828 in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-3)
NCT03556202 ·Status: TERMINATED ·Phase: PHASE3
-
A Study to Test How Well Patients With Plaque Psoriasis Tolerate BI 730357 Over a Longer Period and How Effective it is
NCT03835481 ·Status: TERMINATED ·Phase: PHASE2